FDA Investigator: Zhong Li

- Zhong Li first started conducting FDA inspections in 2015, with the last inspection in 2024. Over that time, Zhong Li has conducted 41 inspections at 37 companies across 40 sites.

Documents

FDA 483 Akeso Biopharma, Co., Ltd., Zhongshan | 2023

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 BeiGene (Suzhou) Co., Ltd., Suzhou | 2023

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Boehringer Ingelheim Biopharmaceuticals (China) Ltd., Shanghai | 2023

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Hugel Inc., Chuncheon | 2023

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Janssen Vaccines Corp., Incheon | 2023

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Alexion Pharma International Operations Unlimited Co., Dublin 15 | 2023

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Patheon Italia S.p.A., Monza | 2022

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Sharp Packaging Services, LLC, Allentown | 2022

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Biocon Biologics Limited, Bengaluru | 2022

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Biocon Biologics Limited, Bengaluru | 2022

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Merck Serono SA Aubonne, Aubonne | 2022

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Curia New Mexico, LLC, Albuquerque | 2022

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Curia New Mexico, LLC, Albuquerque | 2022

Out-of-stock
Zhong Li
Human Drugs Form 483

FDA 483 Kyowa Hakko Kirin Co., Ltd., Takasaki | 2021

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Chugai Pharma Manufacturing Co. Ltd. (CPMC), Kita | 2021

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Macrogenics, Inc, Rockville | 2021

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Sigma-Aldrich Mfg LLC, Saint Louis | 2020

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Baxter Oncology GmbH, Halle (Westf.) | 2019

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Biogen Idec (Denmark) Manufacturing ApS, Hillerod | 2019

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Lonza AG, Visp | 2019

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Genzyme Flanders BVBA, Geel | 2018

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Boehringer Ingelheim Pharma Gmbh & Co Kg, Biberach an der Ris | 2018

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Sanofi Chimie, Division of Sanofi, Vitry Sur Seine | 2018

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Biogen Idec (Denmark) Manufacturing ApS, Hillerod | 2018

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Pfizer Health AB, Strangnas | 2017

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Sandoz GmbH, Langkampfen | 2017

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Samsung Biologics Co., Ltd., Yeonsu-gu | 2017

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 Pfizer Manufacturing Belgium NV, Puurs | 2017

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 AstraZeneca Pharmaceuticals, LP, Frederick | 2017

Out-of-stock
Zhong Li
Human Drug Form 483

FDA 483 McDermott Laboratories Ltd, Baldoyle Dublin 13 | 2016

Out-of-stock
Zhong Li
Human Drug Form 483